Monte Rosa Therapeutics(GLUE.US)

Event Tracking

Jan9

Monte Rosa Therapeutics Signs Underwriting Agreement to Publicly Offer Shares and Warrants

21:36

Monte Rosa Therapeutics CEO Reports Sale of Common Stock

21:06

Monte Rosa Therapeutics Announces $300 Million Firm Commitment Underwritten Public Offering Pricing

03:51

Jan7

Monte Rosa Therapeutics plans to go public and pre-fund warrants

21:22

Monte Rosa Therapeutics showcases pipeline progress and collaborates with Novartis and Roche

12:37

Monte Rosa Therapeutics Reports Encouraging Early Trial Results for Heart Drug MRT-8102

12:15

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 12.77 M, Net Income -27.08 M, EPS -0.3299

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 23.19 M, Net Income -12.3 M, EPS -0.1499

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 84.93 M, Net Income 46.89 M, EPS 0.5699

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change